Search research articles
Contact Us
Filters
Showing results (201-210 of 268) with videos related to
Page
of 27
Sort By:
Frontiers in Endocrinology
|
April 1, 2021
Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands
Maria Fleseriu, Mark Molitch, Alexander Dreval, et al.
Endocrine
|
November 26, 2013
Can we predict long-term remission after somatostatin analog withdrawal in patients with acromegaly? Results from a multicenter prospective trial
Lucio Vilar, Maria Fleseriu, Luciana Ansaneli Naves, et al.
European Journal of Endocrinology
|
October 6, 2025
Osilodrostat dose impact on efficacy/safety in Cushing's disease: large, pooled analysis of LINC 2, 3, and 4
Maria Fleseriu, Rosario Pivonello, André Lacroix, et al.
International Journal of Endocrinology
|
June 28, 2022
Development of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims Database
Kevin C J Yuen, Anna Camilla Birkegard, Lewis S Blevins, et al.
Endocrine
|
April 28, 2021
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant
Sabrina Chiloiro, Antonella Giampietro, Felicia Visconti, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 16, 2014
LCI699, a potent 11β-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study
Xavier Bertagna, Rosario Pivonello, Maria Fleseriu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 15, 2023
MPOWERED Trial Open-Label Extension: Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly
Maria Fleseriu, Mark Molitch, Alexander Dreval, et al.
Pituitary
|
September 2, 2020
Cystic appearance on magnetic resonance imaging in bihormonal growth hormone and prolactin tumors in acromegaly
Elena V Varlamov, Matthew D Wood, Joao Prola Netto, et al.
The Lancet. Diabetes & Endocrinology
|
September 23, 2019
Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial
Maria Fleseriu, Rosario Pivonello, Atanaska Elenkova, et al.
Pituitary
|
October 2, 2019
A tale of pituitary adenomas: to NET or not to NET : Pituitary Society position statement
Ken K Y Ho, Maria Fleseriu, John Wass, et al.
Page
of 27
Search research articles
Search
Showing results (201-210 of 268) with videos related to
Sort By:
Page
of 27
Frontiers in Endocrinology
|
April 1, 2021
Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands
Maria Fleseriu, Mark Molitch, Alexander Dreval, et al.
Endocrine
|
November 26, 2013
Can we predict long-term remission after somatostatin analog withdrawal in patients with acromegaly? Results from a multicenter prospective trial
Lucio Vilar, Maria Fleseriu, Luciana Ansaneli Naves, et al.
European Journal of Endocrinology
|
October 6, 2025
Osilodrostat dose impact on efficacy/safety in Cushing's disease: large, pooled analysis of LINC 2, 3, and 4
Maria Fleseriu, Rosario Pivonello, André Lacroix, et al.
International Journal of Endocrinology
|
June 28, 2022
Development of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims Database
Kevin C J Yuen, Anna Camilla Birkegard, Lewis S Blevins, et al.
Endocrine
|
April 28, 2021
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant
Sabrina Chiloiro, Antonella Giampietro, Felicia Visconti, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 16, 2014
LCI699, a potent 11β-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study
Xavier Bertagna, Rosario Pivonello, Maria Fleseriu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 15, 2023
MPOWERED Trial Open-Label Extension: Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly
Maria Fleseriu, Mark Molitch, Alexander Dreval, et al.
Pituitary
|
September 2, 2020
Cystic appearance on magnetic resonance imaging in bihormonal growth hormone and prolactin tumors in acromegaly
Elena V Varlamov, Matthew D Wood, Joao Prola Netto, et al.
The Lancet. Diabetes & Endocrinology
|
September 23, 2019
Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial
Maria Fleseriu, Rosario Pivonello, Atanaska Elenkova, et al.
Pituitary
|
October 2, 2019
A tale of pituitary adenomas: to NET or not to NET : Pituitary Society position statement
Ken K Y Ho, Maria Fleseriu, John Wass, et al.
Page
of 27